Please login to the form below

Not currently logged in
Email:
Password:

Kantar

This page shows the latest Kantar news and features for those working in and with pharma, biotech and healthcare.

Health activators lack confidence in primary healthcare

Health activators lack confidence in primary healthcare

Based on findings from Kantar Health's National Health and Wellness Survey, the report explores how healthcare decision-makers - or 'health activators' - influence the care of their own and their families' ... providers. Kathy Annunziata, vice president

Latest news

  • Pharma spent $342m on journal advertising in first half of 2014 Pharma spent $342m on journal advertising in first half of 2014

    Kantar Media says its research shows a 1% rise in pharma's print journal advertising and it names Johnson &Johnson - whose spending of almost $23m on advertising drugs products accounts for ... Kantar says the total number of advertising pages purchased

  • Print health ad spend in US remains buoyant Print health ad spend in US remains buoyant

    Forest Laboratories spent 34 per cent less, year on year, while the others significantly increased their spend, according to data from Kantar Media. ... Kantar's research indicates that print is still a main choice for pharma, however, with Johnson

  • WPP to exploit social media data WPP to exploit social media data

    WPP companies, including Cohn &Wolfe and Kantar, will be able to filter and contextualise social data through KBM Group's I-Behavior Zipline digital management platform, or DMP. ... Nick Nyhan, chief digital officer of Kantar and CEO of The Data Alliance

  • Community research Community research

    vice president, integrated strategies and digital solutions, Kantar Health.

  • Millward Brown aligns digital offering

    expertise. The alignment of the businesses, owned by WPP's Kantar, has been prompted by the increasing importance of digital servies to Millward Brown clients. “

More from news
Approximately 5 fully matching, plus 26 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 12 partially matching documents found.

Latest appointments

More from appointments
Approximately 9 fully matching, plus 11 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 2 fully matching, plus 7 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Syneos Health™

Syneos Health™ is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract...

Latest intelligence

Theresa Heggie
Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe
Theresa Heggie talks about the biotech’s 16-year path to market, and the promise of its ‘gene silencing’ medicines...
patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...

Infographics